Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome02:18

The Proteasome

3.5K
3.5K
The Proteasome Structure01:17

The Proteasome Structure

804
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
804
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

3.8K
3.8K
Proteomics01:33

Proteomics

7.4K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

211
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
211

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The vacuolar tauopathy-associated mutation D395G confers redox sensitivity to p97/VCP.

bioRxiv : the preprint server for biology·2026
Same author

Plasticity in the structure and assembly of proteasomes.

The Journal of biological chemistry·2026
Same author

Cdc5-mediated Ulp2 phosphorylation controls the timing of polySUMOylation during the cell cycle.

The Journal of cell biology·2026
Same author

Structures of the 26<i>S</i> proteasome in complex with the Hsp70 co-chaperone Bag1 reveal a mechanism for direct substrate transfer.

Science advances·2026
Same author

A microsporidial deubiquitinase blocks ubiquitin transfer from adenylated E1 to human UBE2K ubiquitin conjugating enzyme.

bioRxiv : the preprint server for biology·2025
Same author

Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles.

The Journal of biological chemistry·2025

Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

890

An unstructured proteasome inhibitor comes into focus.

Antonia A Nemec1, Robert J Tomko1

  • 1Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, Florida, USA.

The Journal of Biological Chemistry
|August 10, 2023
PubMed
Summary

The mechanism of a disordered proteasome inhibitor is now clear, thanks to cryo-electron microscopy. This reveals how it inhibits proteasome activity and opens new questions about proteasome subpopulations.

More Related Videos

Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry
11:54

Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry

Published on: March 23, 2020

9.6K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.8K

Related Experiment Videos

Last Updated: Jul 19, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

890
Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry
11:54

Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry

Published on: March 23, 2020

9.6K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.8K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Cell Biology

Background:

  • An intrinsically disordered proteasome inhibitor, known for over 30 years, has lacked a clear mechanism of action.
  • Proteasome inhibitors are crucial in various cellular processes and disease treatments.

Purpose of the Study:

  • To elucidate the inhibitory mechanism of a long-standing intrinsically disordered proteasome inhibitor.
  • To resolve questions regarding multisite inhibition of proteasomal protease activity.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) was used to determine the inhibitor-proteasome structure.
  • Biochemical assays were performed to validate the inhibitory mechanism.
  • Cell-based experiments were conducted to assess the inhibitor's effects in a biological context.

Main Results:

  • The cryo-EM structure revealed the precise binding mode and inhibitory mechanism of the disordered proteasome inhibitor.
  • Biochemical and cell-based data confirmed multisite inhibition of proteasomal protease activity.
  • The study provides a structural basis for understanding how this inhibitor functions.

Conclusions:

  • The inhibitory mechanism of the intrinsically disordered proteasome inhibitor has been definitively revealed.
  • The findings clarify how multisite inhibition is achieved, advancing our understanding of proteasome regulation.
  • New questions arise regarding the heterogeneity of proteasome subpopulations and their functional implications.